Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors

被引：0
|
作者：
Igawa, Yukiko Shimoda
Yoshida, Tatsuya
Yoshinami, Yuri
Hibino, Yukiko
Arima, Takamichi
Sato, Jun
Maruki, Yuta
Shoji, Hirokazu
Namikawa, Kenjiro
Sudo, Kazuki
Honma, Yoshitaka
Hashimoto, Hironobu
Yamazaki, Naoya
Okusaka, Takuji
Yonemori, Kan
Yamamoto, Noboru
Ohe, Yuichiro
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
[3] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Dept Pharm, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[7] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[8] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12133
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
    Gault, A.
    Anderson, A. E.
    Plummer, R.
    Stewart, C.
    Pratt, A. G.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (02) : 263 - 271
  • [32] Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor
    Robert, Lucie
    Langner-Lemercier, Sophie
    Angibaud, Alexis
    Sale, Alexandre
    Thepault, Fanny
    Corre, Romain
    Lena, Herve
    Ricordel, Charles
    CLINICAL LUNG CANCER, 2020, 21 (05) : E474 - E477
  • [33] Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis
    Ngamphaiboon, Nuttapong
    Ithimakin, Suthinee
    Siripoon, Teerada
    Sintawichai, Nattaya
    Sriuranpong, Virote
    BMC CANCER, 2021, 21 (01)
  • [34] Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis
    Nuttapong Ngamphaiboon
    Suthinee Ithimakin
    Teerada Siripoon
    Nattaya Sintawichai
    Virote Sriuranpong
    BMC Cancer, 21
  • [35] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [36] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [37] PHYSICIAN AWARENESS OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Araujo, F.
    Fonseca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1777 - 1778
  • [38] Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Eltobgy, Mostafa
    Oweira, Hani
    Giryes, Anwar
    Tekbas, Aysun
    Decker, Michael
    IMMUNOTHERAPY, 2017, 9 (14) : 1175 - 1183
  • [39] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [40] Racial disparities in immune-related adverse events in patients with lung cancer treated with immune checkpoint inhibitors
    Chandani, K. Uttam
    Agrawal, S.
    Raval, M.
    Khan, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1176 - S1176
12345